Protara Therapeutics Inc. (TARA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Protara Therapeutics Inc.

    NASDAQ: TARA · Real-Time Price · USD
    4.38
    0.13 (3.06%)
    At close: Sep 29, 2025, 3:12 PM

    Protara Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 332K 341K 247K 1.17M
    Gross Profit
    		 -332K -341K -247K -1.17M
    Operating Income
    		 -49.15M -43.61M -67.06M -47.49M
    Interest Income
    		 4.13M 2.73M 1.11M 237K
    Pretax Income
    		 -44.6M -40.42M -65.95M -47.25M
    Net Income
    		 -44.6M -40.42M -65.95M -47.13M
    Selling & General & Admin
    		 17.45M 18.62M 20.74M 26.4M
    Research & Development
    		 31.7M 24.79M 16.81M 21.09M
    Other Expenses
    		 -332K -137K -247K n/a
    Operating Expenses
    		 48.82M 43.27M 37.3M 47.49M
    Interest Expense
    		 n/a n/a 1.14M 1.74M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 49.15M 43.61M 37.55M 47.49M
    Income Tax Expense
    		 n/a n/a -1.14M -117K
    Shares Outstanding (Basic)
    		 20.59M 11.33M 11.26M 11.23M
    Shares Outstanding (Diluted)
    		 20.59M 11.33M 11.26M 11.23M
    EPS (Basic)
    		 -2.17 -3.57 -5.86 -4.2
    EPS (Diluted)
    		 -2.17 -3.57 -5.86 -4.2
    EBITDA
    		 -49.15M -43.27M -64.57M -46.09M
    EBIT
    		 -40.42M -43.61M -64.81M -47.25M
    Depreciation & Amortization
    		 -8.73M 341K 247K 1.17M

    Add to Watchlist